364 related articles for article (PubMed ID: 9712077)
41. Anti-β2-glycoprotein I paratopes and β2-glycoprotein I epitopes characterization using random peptide libraries.
Zager U; Kveder T; Cučnik S; Božič B; Lunder M
Autoimmunity; 2014 Nov; 47(7):438-44. PubMed ID: 24819195
[TBL] [Abstract][Full Text] [Related]
42. Phospholipid-independent binding of beta 2glycoprotein I by IgA from patients with antiphospholipid syndrome.
Galazka MW; Keil LB; Kohles J; Petersheim M; DeBari VA
Ann Clin Lab Sci; 1998; 28(3):153-9. PubMed ID: 9646856
[TBL] [Abstract][Full Text] [Related]
43. Sulfatides: targets for anti-phospholipid antibodies.
Merten M; Motamedy S; Ramamurthy S; Arnett FC; Thiagarajan P
Circulation; 2003 Oct; 108(17):2082-7. PubMed ID: 14530197
[TBL] [Abstract][Full Text] [Related]
44. Beta2-glycoprotein I, anti-beta2-glycoprotein I, and fibrinolysis.
Yasuda S; Atsumi T; Ieko M; Koike T
Thromb Res; 2004; 114(5-6):461-5. PubMed ID: 15507279
[TBL] [Abstract][Full Text] [Related]
45. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.
von Scheven E; Glidden DV; Elder ME
Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489
[TBL] [Abstract][Full Text] [Related]
46. A novel mechanism of thrombosis in antiphospholipid antibody syndrome.
Vlachoyiannopoulos PG; Routsias JG
J Autoimmun; 2010 Nov; 35(3):248-55. PubMed ID: 20638238
[TBL] [Abstract][Full Text] [Related]
47. Clinical significance of anti-beta 2-glycoprotein I antibodies.
Amengual O; Atsumi T; Khamashta MA; Hughes GR
Ann Med Interne (Paris); 1996 Sep; 147 Suppl 1():15-7. PubMed ID: 8952753
[TBL] [Abstract][Full Text] [Related]
48. Beta2-glycoprotein I is proteolytically cleaved in vivo upon activation of fibrinolysis.
Horbach DA; van Oort E; Lisman T; Meijers JC; Derksen RH; de Groot PG
Thromb Haemost; 1999 Jan; 81(1):87-95. PubMed ID: 10348717
[TBL] [Abstract][Full Text] [Related]
49. [Anti-beta2 glycoprotein I-beta2 glycoprotein I] immune complexes in patients with antiphospholipid syndrome and other autoimmune diseases.
Biasiolo A; Rampazzo P; Brocco T; Barbero F; Rosato A; Pengo V
Lupus; 1999; 8(2):121-6. PubMed ID: 10192506
[TBL] [Abstract][Full Text] [Related]
50. High avidity anti-beta 2-glycoprotein I antibodies in patients with antiphospholipid syndrome.
Cucnik S; Kveder T; Krizaj I; Rozman B; Bozic B
Ann Rheum Dis; 2004 Nov; 63(11):1478-82. PubMed ID: 15479898
[TBL] [Abstract][Full Text] [Related]
51. Beta2-glycoprotein I: target antigen for 'antiphospholipid' antibodies. Immunological and molecular aspects.
Sheng Y; Kandiah DA; Krilis SA
Lupus; 1998; 7 Suppl 2():S5-9. PubMed ID: 9814663
[TBL] [Abstract][Full Text] [Related]
52. IgG anti-beta(2) glycoprotein I antibodies in Malaysian patients with antiphospholipid syndrome and systemic lupus erythematosus: prevalence and clinical correlations.
Ong SG; Cheng HM; Soon SC; Goh E; Chow SK; Yeap SS
Clin Rheumatol; 2002 Sep; 21(5):382-5. PubMed ID: 12223986
[TBL] [Abstract][Full Text] [Related]
53. Beta-2 glycoprotein I and its role in antiphospholipid syndrome-lessons from knockout mice.
Miyakis S; Robertson SA; Krilis SA
Clin Immunol; 2004 Aug; 112(2):136-43. PubMed ID: 15240156
[TBL] [Abstract][Full Text] [Related]
54. Anti-beta2 glycoprotein I (beta2GPI) autoantibodies recognize an epitope on the first domain of beta2GPI.
Iverson GM; Victoria EJ; Marquis DM
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15542-6. PubMed ID: 9861005
[TBL] [Abstract][Full Text] [Related]
55. Autoantibodies against malondialdehyde-modified lipoprotein(a) in antiphospholipid syndrome.
Romero FI; Atsumi T; Tinahones FJ; Gómez-Zumaquero JM; Amengual O; Khamashta MA; Hughes GR
Arthritis Rheum; 1999 Dec; 42(12):2606-11. PubMed ID: 10616007
[TBL] [Abstract][Full Text] [Related]
56. The orientation of beta2GPI on the plate is important for the binding of anti-beta2GPI autoantibodies by ELISA.
Iverson GM; Matsuura E; Victoria EJ; Cockerill KA; Linnik MD
J Autoimmun; 2002 Jun; 18(4):289-97. PubMed ID: 12144810
[TBL] [Abstract][Full Text] [Related]
57. Induction of anti-phospholipid autoantibodies by beta2-glycoprotein I bound to apoptotic thymocytes.
Levine JS; Subang R; Koh JS; Rauch J
J Autoimmun; 1998 Oct; 11(5):413-24. PubMed ID: 9802924
[TBL] [Abstract][Full Text] [Related]
58. Induction of antiphospholipid antibodies and antiphospholipid syndrome-like autoimmunity in naive mice with antibody against human parvovirus B19 VP1 unique region protein.
Tzang BS; Lee YJ; Yang TP; Tsay GJ; Shi JY; Tsai CC; Hsu TC
Clin Chim Acta; 2007 Jul; 382(1-2):31-6. PubMed ID: 17451664
[TBL] [Abstract][Full Text] [Related]
59. β2-Glycoprotein-I based peptide regulate endothelial-cells tissue-factor expression via negative regulation of pGSK3β expression and reduces experimental-antiphospholipid-syndrome.
Blank M; Baraam L; Eisenstein M; Fridkin M; Dardik R; Heldman Y; Katchalski-Katzir E; Shoenfeld Y
J Autoimmun; 2011 Aug; 37(1):8-17. PubMed ID: 21524885
[TBL] [Abstract][Full Text] [Related]
60. Phospholipid-bound beta 2-glycoprotein I induces the production of anti-phospholipid antibodies.
Subang R; Levine JS; Janoff AS; Davidson SM; Taraschi TF; Koike T; Minchey SR; Whiteside M; Tannenbaum M; Rauch J
J Autoimmun; 2000 Aug; 15(1):21-32. PubMed ID: 10936025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
